{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:15:38Z","timestamp":1789503338310,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jsat.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T15:01:21Z","timestamp":1483023681000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample"],"prefix":"10.1016","volume":"74","author":[{"given":"Eline Borger","family":"Rognli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bukten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2016.12.007_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1196\/annals.1369.012","article-title":"Longitudinal clinical course following pharmacological treatment of metamphetamie psychosis which persists after long-term abstinence","volume":"1074","author":"Akiyama","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jsat.2016.12.007_bb0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1521-0391.2011.00124.x","article-title":"Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients","volume":"20","author":"Akiyama","year":"2011","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1016\/j.jsat.2016.12.007_bb0015","first-page":"95","article-title":"The phenomenology of experimentally induced amphetamine psychosis: Preliminary observations","volume":"2","author":"Angrist","year":"1970","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.187.6.510","article-title":"Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases","volume":"187","author":"Arendt","year":"2005","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0025","series-title":"Guidelines for use in primary care","article-title":"The alcohol use disorders identification test","volume":"2","author":"Babor","year":"2001"},{"key":"10.1016\/j.jsat.2016.12.007_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpsyc.1973.04200010020003","article-title":"The experimental reproduction of amphetamine psychosis","volume":"29","author":"Bell","year":"1973","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0035","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/schbul\/sbr003","article-title":"Testing the psychosis continuum: Differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis","volume":"38","author":"Binbay","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2016.12.007_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1471-244X-12-221","article-title":"Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable?","volume":"12","author":"Bramness","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.jsat.2016.12.007_bb0045","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1176\/appi.ajp.162.4.774","article-title":"Psychosis in the community and in prisons: A report from the British National Survey of psychiatric morbidity","volume":"162","author":"Brugha","year":"2014","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0050","first-page":"59","article-title":"The Norwegian offender mental health and addiction study\u2013design and implementation of a national survey and prospective cohort study","volume":"9","author":"Bukten","year":"2015","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.jsat.2016.12.007_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1176\/appi.ajp.2011.10070937","article-title":"Methamphetamine use and schizophrenia: A population-based cohort study in California","volume":"169","author":"Callaghan","year":"2012","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2016.12.007_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/dar.12280","article-title":"Associations between psychotic symptoms and substance use in young offenders","volume":"34","author":"Degenhardt","year":"2015","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2016.12.007_bb0065","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2016.12.007_bb0070","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsat.2016.12.007_bb0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00005053-199111000-00007","article-title":"Screening for psychosis in the general population with a self-report interview","volume":"179","author":"Eaton","year":"1991","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2016.12.007_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/09638237.2012.745184","article-title":"Clinical features of inpatients with methamphetamine-induced psychosis","volume":"22","author":"Fasihpour","year":"2013","journal-title":"Journal of Mental Health"},{"key":"10.1016\/j.jsat.2016.12.007_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(02)07740-1","article-title":"Serious mental disorder in 23000 prisoners: A systematic review of 62 surveys","volume":"359","author":"Fazel","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jsat.2016.12.007_bb0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1192\/bjp.bp.111.096370","article-title":"Severe mental illness in 33 588 prisoners worldwide: Systematic review and meta-regression analysis","volume":"200","author":"Fazel","year":"2012","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: A systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.jsat.2016.12.007_bb0100","first-page":"1010","article-title":"Mental disorders among adolescents in juvenile detention and correctional facilities: A systematic review and metaregression analysis of 25 surveys","volume":"47","author":"Fazel","year":"2008","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291702006402","article-title":"Cannabis dependence and psychotic symptoms in young people","volume":"33","author":"Fergusson","year":"2003","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jsat.2016.12.007_bb0110","first-page":"sbu098","article-title":"How cannabis causes paranoia: Using the intravenous administration of \u2206 9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia","author":"Freeman","year":"2014","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1016\/j.jsat.2016.12.007_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11481-011-9288-1","article-title":"Methamphetamine-associated psychosis","volume":"7","author":"Grant","year":"2011","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.jsat.2016.12.007_bb0120","first-page":"39","article-title":"Paranoid episodes induced by drugs","volume":"205","author":"Griffiths","year":"1968","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2016.12.007_bb0125","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1176\/ajp.153.9.1195","article-title":"Psychiatric Research Interview for Substance and Mental Disorders (PRISM): Reliability for substance abusers","volume":"153","author":"Hasin","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0130","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0272-7358(01)00103-9","article-title":"The continuity of psychotic experiences in the general population","volume":"21","author":"Johns","year":"2001","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jsat.2016.12.007_bb0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1477370811413819","article-title":"Exceptional prison conditions and the quality of prison life: Prison size and prison culture in Norwegian closed prisons","volume":"8","author":"Johnsen","year":"2011","journal-title":"European Journal of Criminology"},{"key":"10.1016\/j.jsat.2016.12.007_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1465-3362.2010.00196.x","article-title":"Long-term outcomes in methamphetamine psychosis patients after first hospitalisation","volume":"29","author":"Kittirattanapaiboon","year":"2010","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2016.12.007_bb0145","article-title":"Correctional statistics of Denmark, Finland, Iceland, Norway and Sweden 2009\u20132013","author":"Kristoffersen","year":"2014","journal-title":"Kriminalomsorgen"},{"key":"10.1016\/j.jsat.2016.12.007_bb0150","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/NMD.0000000000000059","article-title":"Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment","volume":"201","author":"Lecomte","year":"2013","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2016.12.007_bb0155","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1017\/S0033291712001626","article-title":"An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: On the pathway from proneness to persistence to dimensional expression across mental disorders","volume":"43","author":"Linscott","year":"2013","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jsat.2016.12.007_bb0160","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1360-0443.2010.02932.x","article-title":"Health outcomes associated with methamphetamine use among young people: A systematic review","volume":"105","author":"Marshall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.12.007_bb0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1465-3362.2009.00160.x","article-title":"The risk of psychotic symptoms associated with recreational methamphetamine use","volume":"29","author":"McKetin","year":"2010","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2016.12.007_bb0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","article-title":"Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study","volume":"70","author":"McKetin","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/ajad.12274","article-title":"Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample","author":"Medhus","year":"2015","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2016.12.007_bb0180","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous \u0394 9-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jsat.2016.12.007_bb0185","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.4088\/JCP.12m07822","article-title":"Substance-induced psychoses converting into schizophrenia: A register-based study of 18,478 Finnish inpatient cases","volume":"74","author":"Niemi-Pyntt\u00e4ri","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/schbul\/sbq099","article-title":"The continuum of psychotic symptoms in the general population: A cross-national study","volume":"38","author":"Nuevo","year":"2012","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jsat.2016.12.007_bb0195","first-page":"21","article-title":"Drug and alcohol problems among Norwegian inmates","volume":"25","author":"\u00d8deg\u00e5rd","year":"2008","journal-title":"Nordisk Alkohol-& Narkotikatidskrift (NAT)"},{"key":"10.1016\/j.jsat.2016.12.007_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/bjc\/azm072","article-title":"Scandinavian exceptionalism in an era of penal excess part I: The nature and roots of scandinavian exceptionalism","volume":"48","author":"Pratt","year":"2008","journal-title":"British Journal of Criminology"},{"key":"10.1016\/j.jsat.2016.12.007_bb0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40429-015-0077-4","article-title":"Understanding the relationship between amphetamines and psychosis","volume":"2","author":"Rognli","year":"2015","journal-title":"Current Addiction Reports"},{"key":"10.1016\/j.jsat.2016.12.007_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.01.002","article-title":"Psychotic experiences in the general population: A twenty-year prospective community study","volume":"92","author":"R\u00f6ssler","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2016.12.007_bb0215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1992.tb25965.x","article-title":"A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis","volume":"654","author":"Sato","year":"1992","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jsat.2016.12.007_bb0220","article-title":"Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis","author":"Sato","year":"1983","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.comppsych.2008.07.009","article-title":"Prevalence of psychotic symptoms in substance users: A comparison across substances","volume":"50","author":"Smith","year":"2009","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0230","series-title":"National Penal Code. Lov 25.05.2005","author":"Straffeloven","year":"2005"},{"key":"10.1016\/j.jsat.2016.12.007_bb0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08039480310000932","article-title":"Measuring the mental health status of the Norwegian population: A comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36)","volume":"57","author":"Strand","year":"2003","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0240","doi-asserted-by":"crossref","DOI":"10.1097\/00005053-199008000-00001","article-title":"Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences","volume":"178","author":"Tien","year":"1990","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2016.12.007_bb0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1196\/annals.1316.035","article-title":"Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis","volume":"1025","author":"Ujike","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jsat.2016.12.007_bb0250","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/10629360600810434","article-title":"Fully conditional specification in multivariate imputation","volume":"76","author":"Van Buuren","year":"2006","journal-title":"Journal of Statistical Computation and Simulation"},{"key":"10.1016\/j.jsat.2016.12.007_bb0255","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2014.04.023","article-title":"Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences","volume":"157","author":"Van Gastel","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2016.12.007_bb0260","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamapsychiatry.2014.1068","article-title":"The many continua of psychosis","volume":"71","author":"Van Os","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.007_bb0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0033291708003814","article-title":"A systematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness-persistence-impairment model of psychotic disorder","volume":"39","author":"Van Os","year":"2009","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jsat.2016.12.007_bb0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(01)00352-8","article-title":"Psychotic symptoms in non-clinical populations and the continuum of psychosis","volume":"54","author":"Verdoux","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2016.12.007_bb0275","series-title":"World prison population list","author":"World Prison Brief","year":"2015"},{"key":"10.1016\/j.jsat.2016.12.007_bb0280","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamapsychiatry.2014.994","article-title":"Consistent etiology of severe, frequent psychotic experiences and milder, less frequent manifestations: A twin study of specific psychotic experiences in adolescence","volume":"71","author":"Zavos","year":"2014","journal-title":"JAMA Psychiatry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216303051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216303051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:45:38Z","timestamp":1760039138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216303051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":56,"alternative-id":["S0740547216303051"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.12.007","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}